Cargando…

Prevalence of underlying gastrointestinal malignancies in iron‐deficient heart failure

AIMS: Anaemia and iron deficiency (ferritin level < 100 or 100–300 μg/L with transferrin saturation < 20%) are prevalent in heart failure. Mechanistically, iron deficiency is linked to poor intestinal uptake, increased intestinal loss, and chronic inflammation. However, the prevalence of under...

Descripción completa

Detalles Bibliográficos
Autores principales: Martens, Pieter, Minten, Lennert, Dupont, Matthias, Mullens, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351899/
https://www.ncbi.nlm.nih.gov/pubmed/30415506
http://dx.doi.org/10.1002/ehf2.12379
_version_ 1783390688088424448
author Martens, Pieter
Minten, Lennert
Dupont, Matthias
Mullens, Wilfried
author_facet Martens, Pieter
Minten, Lennert
Dupont, Matthias
Mullens, Wilfried
author_sort Martens, Pieter
collection PubMed
description AIMS: Anaemia and iron deficiency (ferritin level < 100 or 100–300 μg/L with transferrin saturation < 20%) are prevalent in heart failure. Mechanistically, iron deficiency is linked to poor intestinal uptake, increased intestinal loss, and chronic inflammation. However, the prevalence of underlying gastrointestinal malignancies is not established in iron‐deficient heart failure with or without anaemia. METHODS AND RESULTS: Patients followed up in a single‐centre, heart failure database with baseline registration of haemoglobin and iron status were retrospectively evaluated. The proportion of patients undergoing upper and lower gastrointestinal endoscopy between inclusion and censoring was determined. Afterwards, the prevalence of biopsy that confirmed intestinal malignancies in relation to baseline iron and haemoglobin status was determined. Anaemia was defined as a haemoglobin level <12 g/dL, and iron deficiency according to the aforementioned criteria. Of the 1197 patients in the database, 699 (59%) patients underwent full endoscopic workup over a mean follow‐up of 50 ± 27 months. A total of 50 intestinal malignancies were identified (n = 42, 84%, in iron‐deficient vs. n = 8, 16%, non‐iron‐deficient patients; P < 0.001). The prevalence of intestinal malignancies was non‐statistically different in iron‐deficient patients with anaemia (n = 12/129, 9.3%) or without anaemia (n = 30/287, 10.5%; P = 0.551). The prevalence was much lower in patients without iron deficiency with anaemia (n = 5/83, 6%) or without anaemia (n = 3/200, 1.5%). In patients with iron deficiency but without anaemia (a group in which the role of endoscopic workup is less established), ferritin levels carried an inverse diagnostic capacity in detecting patients with an underlying malignancy (area under the curve = 0.741, P < 0.001). A ferritin level < 56 μg/L had the best acuity, detecting malignancies with a sensitivity of 80% and a specificity of 71%. CONCLUSIONS: Endoscopic evaluation is warranted in heart failure patients with iron‐deficient anaemia given the high prevalence of underlying intestinal malignancies, as advised by gastroenterology guidelines. However, additional research is needed assessing the best approach to patients with iron deficiency without anaemia, given the high occurrence of intestinal malignancies in these patients. A lower ferritin level could potentially help stratify the need for an endoscopic workup in these patients.
format Online
Article
Text
id pubmed-6351899
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63518992019-02-06 Prevalence of underlying gastrointestinal malignancies in iron‐deficient heart failure Martens, Pieter Minten, Lennert Dupont, Matthias Mullens, Wilfried ESC Heart Fail Original Research Articles AIMS: Anaemia and iron deficiency (ferritin level < 100 or 100–300 μg/L with transferrin saturation < 20%) are prevalent in heart failure. Mechanistically, iron deficiency is linked to poor intestinal uptake, increased intestinal loss, and chronic inflammation. However, the prevalence of underlying gastrointestinal malignancies is not established in iron‐deficient heart failure with or without anaemia. METHODS AND RESULTS: Patients followed up in a single‐centre, heart failure database with baseline registration of haemoglobin and iron status were retrospectively evaluated. The proportion of patients undergoing upper and lower gastrointestinal endoscopy between inclusion and censoring was determined. Afterwards, the prevalence of biopsy that confirmed intestinal malignancies in relation to baseline iron and haemoglobin status was determined. Anaemia was defined as a haemoglobin level <12 g/dL, and iron deficiency according to the aforementioned criteria. Of the 1197 patients in the database, 699 (59%) patients underwent full endoscopic workup over a mean follow‐up of 50 ± 27 months. A total of 50 intestinal malignancies were identified (n = 42, 84%, in iron‐deficient vs. n = 8, 16%, non‐iron‐deficient patients; P < 0.001). The prevalence of intestinal malignancies was non‐statistically different in iron‐deficient patients with anaemia (n = 12/129, 9.3%) or without anaemia (n = 30/287, 10.5%; P = 0.551). The prevalence was much lower in patients without iron deficiency with anaemia (n = 5/83, 6%) or without anaemia (n = 3/200, 1.5%). In patients with iron deficiency but without anaemia (a group in which the role of endoscopic workup is less established), ferritin levels carried an inverse diagnostic capacity in detecting patients with an underlying malignancy (area under the curve = 0.741, P < 0.001). A ferritin level < 56 μg/L had the best acuity, detecting malignancies with a sensitivity of 80% and a specificity of 71%. CONCLUSIONS: Endoscopic evaluation is warranted in heart failure patients with iron‐deficient anaemia given the high prevalence of underlying intestinal malignancies, as advised by gastroenterology guidelines. However, additional research is needed assessing the best approach to patients with iron deficiency without anaemia, given the high occurrence of intestinal malignancies in these patients. A lower ferritin level could potentially help stratify the need for an endoscopic workup in these patients. John Wiley and Sons Inc. 2018-11-10 /pmc/articles/PMC6351899/ /pubmed/30415506 http://dx.doi.org/10.1002/ehf2.12379 Text en © 2018 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research Articles
Martens, Pieter
Minten, Lennert
Dupont, Matthias
Mullens, Wilfried
Prevalence of underlying gastrointestinal malignancies in iron‐deficient heart failure
title Prevalence of underlying gastrointestinal malignancies in iron‐deficient heart failure
title_full Prevalence of underlying gastrointestinal malignancies in iron‐deficient heart failure
title_fullStr Prevalence of underlying gastrointestinal malignancies in iron‐deficient heart failure
title_full_unstemmed Prevalence of underlying gastrointestinal malignancies in iron‐deficient heart failure
title_short Prevalence of underlying gastrointestinal malignancies in iron‐deficient heart failure
title_sort prevalence of underlying gastrointestinal malignancies in iron‐deficient heart failure
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351899/
https://www.ncbi.nlm.nih.gov/pubmed/30415506
http://dx.doi.org/10.1002/ehf2.12379
work_keys_str_mv AT martenspieter prevalenceofunderlyinggastrointestinalmalignanciesinirondeficientheartfailure
AT mintenlennert prevalenceofunderlyinggastrointestinalmalignanciesinirondeficientheartfailure
AT dupontmatthias prevalenceofunderlyinggastrointestinalmalignanciesinirondeficientheartfailure
AT mullenswilfried prevalenceofunderlyinggastrointestinalmalignanciesinirondeficientheartfailure